THE Cass Review “obscures key findings, misrepresents its own data, and is rife with misapplications of the scientific method”, according to a review by academics from Yale Law School and the Yale School of Medicine.
It led to the NHS in Scotland pausing the prescription of puberty blockers and hormone treatments to new patients under-18 after Cass claimed there was “remarkably weak” evidence on medical interventions.According to McNamara, the review “levies unsupported assertions about gender identity, gender dysphoria, standard practices, and safety of gender-affirming medical treatments” and “repeats claims that have been disproved by sound evidence.
“The review will likely be cited by states attempting to ban gender-affirming care, but, in fact, it is does not recommend a ban on medical care for transgender youth.”“The Cass Review is an important document for those considering how to remedy the shortage of health services for transgender young people in the U.K,” said McNamara.
The damning assessment throws into doubt the accuracy of Cass’s review and the policy decisions which have been taken in its wake, including the ban on puberty blockers and hormone therapy for under-18s in Scotland.Why are you making commenting on The National only available to subscribers?
Education Education Latest News, Education Education Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: TIME - 🏆 93. / 53 Read more »